Status: Recruiting
Low INR to Minimize Bleeding With Mechanical Valves Trial
This study evaluates the use of a lower INR target (1.5 to 2.5) in patients with a mechanical bileaflet heart valve in the aortic position. This study will inform physicians about whether a lower INR target will decrease the risk of bleeding or increase the risk of blood clot formation and stroke. These results have the potential to reduce the burden of bleeding in patients with a mechanical heart valve who require lifelong warfarin (Coumadin) treatment.
Participants needed: 2,625
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Population Health Research InstituteUpdated: Jan 6, 2026Locations: 35
Eligibility criteria
Age is 18 or older at the time of enrolment [+2]
Has a second implanted mechanical valve (any position) [+2]